These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6348485)

  • 1. Opipramol in the climacteric syndrome. A double-blind, placebo-controlled trial.
    van Lith ND; Motké JC
    Maturitas; 1983 Jun; 5(1):17-23. PubMed ID: 6348485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination of phenylpyrrolidinopentane (Katovit) and oxazepam (Adumbran). A double-blind comparison with opipramol (Insidon) in depressive syndromes].
    Gmür M; Angst J
    Int Pharmacopsychiatry; 1977; 12(2):100-12. PubMed ID: 330439
    [No Abstract]   [Full Text] [Related]  

  • 3. Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group.
    Möller HJ; Volz HP; Reimann IW; Stoll KD
    J Clin Psychopharmacol; 2001 Feb; 21(1):59-65. PubMed ID: 11199949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A trial of opipramol in the treatment of migraine.
    Jacobs H
    J Neurol Neurosurg Psychiatry; 1972 Aug; 35(4):500-4. PubMed ID: 4559028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oestrogen on the sleep, mood, and anxiety of menopausal women.
    Thomson J; Oswald I
    Br Med J; 1977 Nov; 2(6098):1317-9. PubMed ID: 338104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opipramol improves subjective quality of sleep the night prior to surgery: confirmatory testing of a double-blind, randomized clinical trial.
    Hueppe M; Hartge D; Stoll KD; Ros A; Schmucker P; Gerlach K
    Neuropsychobiology; 2011; 64(1):24-31. PubMed ID: 21577010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Opipramol therapy in personal depressions in ambulatory practice, a double-blind study].
    Kraft TB
    Ned Tijdschr Geneeskd; 1969 May; 113(20):889-92. PubMed ID: 4889805
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12-week randomized, double-blind, placebo-controlled trial.
    Heger M; Ventskovskiy BM; Borzenko I; Kneis KC; Rettenberger R; Kaszkin-Bettag M; Heger PW
    Menopause; 2006; 13(5):744-59. PubMed ID: 16894335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind comparative study of opipramol and amitriptyline in neurotic and endogenous depressions.
    Rajotte P; Bordeleau JM; Tétreault L; Doucet P; Rajotte E
    Can Psychiatr Assoc J; 1966; 11 Suppl():Suppl:159-68. PubMed ID: 5328015
    [No Abstract]   [Full Text] [Related]  

  • 10. A placebo-controlled trial of ethinyl oestradiol and norethisterone in climacteric women.
    Nordin BE; Jones MM; Crilly RG; Marshall DH; Brooke R
    Maturitas; 1980 Oct; 2(3):247-51. PubMed ID: 7003315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Opipramel in the treatment of extragenital complaints of the climacteric].
    Foldes JJ
    Harefuah; 1972 Feb; 82(4):165-6. PubMed ID: 4559642
    [No Abstract]   [Full Text] [Related]  

  • 12. Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial.
    Volz HP; Möller HJ; Reimann I; Stoll KD
    Eur Neuropsychopharmacol; 2000 May; 10(3):211-7. PubMed ID: 10793324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind cross-over study with Org OD 14 and placebo in postmenopausal patients.
    Nevinny-Stickel J
    Arch Gynecol; 1983; 234(1):27-31. PubMed ID: 6660926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern indications for the use of opipramol.
    Krysta K; Murawiec S; Warchala A; Zawada K; Cubała WJ; Wiglusz MS; Jakuszkowiak-Wojten K; Krzystanek M; Krupka-Matuszczyk I
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S435-7. PubMed ID: 26417811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term placebo-controlled efficacy and safety study of Org OD 14 in climacteric women.
    Benedek-Jaszmann LJ
    Maturitas; 1987; Suppl 1():25-33. PubMed ID: 3306289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethamsylate in the treatment of climacteric flushing.
    Harrison RF
    Maturitas; 1981 Mar; 3(1):31-7. PubMed ID: 6789032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of menopausal hot flushes by methyldopa. A double blind crossover trial.
    Nesheim BI; Saetre T
    Eur J Clin Pharmacol; 1981; 20(6):413-6. PubMed ID: 7026262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of desvenlafaxine on mood and climacteric symptoms in menopausal women with moderate to severe vasomotor symptoms.
    Cheng RJ; Dupont C; Archer DF; Bao W; Racketa J; Constantine G; Pickar JH
    Climacteric; 2013 Feb; 16(1):17-27. PubMed ID: 22646219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of opipramol as an evening anaesthesiologic premedication.
    Gerlach K; Uhlig T; Plathof J; Klassen A; Stoll KD; Schmucker P; Hueppe M
    Neuropsychobiology; 2002; 46(3):161-6. PubMed ID: 12422064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soy germ extract alleviates menopausal hot flushes: placebo-controlled double-blind trial.
    Imhof M; Gocan A; Imhof M; Schmidt M
    Eur J Clin Nutr; 2018 Jul; 72(7):961-970. PubMed ID: 29849181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.